Search for: "Mylan Pharmaceuticals, Inc."
Results 21 - 40
of 496
Sorted by Relevance
|
Sort by Date
30 Jun 2011, 2:13 pm
Mylan Inc. et. al. was filed in the U.S. [read post]
9 Dec 2021, 7:15 am
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
8 Dec 2021, 8:52 am
The outcome AstraZeneca AB and AstraZeneca Pharmaceuticals LP (collectively, “AstraZeneca”) sued Mylan Pharmaceuticals Inc. and Kindeva Drug Delivery L.P. [read post]
9 Dec 2021, 7:15 am
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
9 Apr 2008, 8:49 pm
Mylan Laboratories, Inc. [read post]
20 Aug 2017, 7:14 am
Pharmaceutical companies Mylan Inc. and Mylan Specialty L.P. agree to pay $465 million to settle a lawsuit brought under the False Claims Act (FCA). [read post]
17 Mar 2022, 9:06 pm
Mylan Pharmaceuticals Inc. [read post]
8 Nov 2021, 9:15 am
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
25 Aug 2017, 2:25 pm
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
24 Oct 2008, 11:37 am
Swiss-drug major Novartis has filed a lawsuit in the US District Court for the District of New Jersey against Mylan Pharmaceuticals Inc. for infringement of Orange Book listed US Patent No. 5,354,772 (the ‘772 patent) for Lescol capsules, generically known as Fluvastatin Sodium. [read post]
2 Aug 2023, 11:05 am
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
2 Apr 2015, 9:59 pm
The first filer, Mylan Pharmaceuticals, Inc. [read post]
2 May 2016, 6:17 am
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
18 May 2014, 8:42 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc. [read post]
8 Nov 2021, 9:15 am
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
13 Oct 2014, 8:46 pm
• Defendants: Mylan Pharmaceuticals Inc.; Mylan Inc.; Natco Pharma Ltd. [read post]
31 Dec 2010, 3:57 am
The drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
6 Apr 2008, 9:15 pm
Patent No. 4,513,006 to encompass Plaintiff-Appellee Ortho-McNeil Pharmaceutical, Inc.'s epilepsy drug topiramate, and affirmed the District Court's decision to (1) permanently enjoin Defendants-Appellees Mylan... [read post]
25 Aug 2017, 7:02 am
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
25 Aug 2017, 7:02 am
On Thursday, August 17, 2017, the Department of Justice, announced that Mylan Inc. and Mylan Specialty L.P. [read post]
